AzTrials
AzTrials

FibromyalgiaNCT06487741

Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial

A study testing Home-based stretching exercises in people with Fibromyalgia and Stretch, run by University College of Northern Denmark at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomised controlled trial will examine the clinical efficacy of a six-week, novel, home-based stretching programme compared to usual care on the effect of symptoms experienced by patients with fibromyalgia. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Fibromyalgia, Stretch, Adherence, Treatment
What is being tested?
Home-based stretching exercises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteDenmark
Study dates
31 Oct 2024to 30 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • individuals diagnosed with fibromyalgia in accordance with the ACR 2016 diagnostic criteria.
  • individuals diagnosed with chronic non-malignant pain or individuals diagnosed with chronic widespread pain (including fibromyalgia syndrome) are also included when they meet the ACR 2016 diagnostic criteria.

Who cannot join

  • Non-controlled systemic disorders (such as hypertension, diabetes and coronary insufficiency),
  • neurological conditions that impair alertness or comprehension, musculoskeletal conditions that could compromise assessments (such as nerve root compression or knee joint inflammation),
  • relevant joint disorders (such as severe arthritis, arthroplasty of the hip or knee, and rheumatoid arthritis),
  • recent changes in therapy for fibromyalgia (i.e., within four weeks of baseline).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Morten P Støve, PT. Msc. contact

72691004

mps@ucn.dk

Allan Riis, PT. Ph.D. contact

+4572691310

alr@ucn.dk

Denmark1 site, 1 recruiting
  • University College of Northern Denmark

    Aalborg, 9220

    Morten P Støve, PT, Msc., 004522980862, mps@ucn.dk

    Morten P Støve, PT, Msc.

    Recruiting

Other trials in Denmark

About this study

This randomised controlled trial will examine the clinical efficacy of a six-week, novel, home-based stretching programme compared to usual care on the effect of symptoms experienced by patients with fibromyalgia.

Being tested
Home-based stretching exercises
Keywords
Fibromyalgia, Stretching exercises, Home-based, Adherence
Medical subject headings
Fibromyalgia, Treatment Adherence and Compliance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home-based stretching exercisesOther

    The intervention comprises six weeks of daily static stretching exercises (six minutes a day) in accordance with the recommendation of the American College of Sports Medicine. The intervention is self-administered and consists of two bouts of 30-second bilateral static stretches of the knee flexors, hip abductors, and shoulder elevators.

Study groups in NCT06487741
Study groupRoleWhat they receive
InterventionExperimentalThe intervention group receives a home-based rehabilitation program consisting of six weeks of daily static stretching exercises (six minutes a day).
Receives: Other: Home-based stretching exercises
ControlNo interventionThe control group receives usual care, and no change in treatment is made. Participants will be encouraged to maintain their daily routine but refrain from changing the current pharmacological treatment or initiating new physical exercise practices during the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Severity of symptoms

    The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score

    Measured: Measured at baseline

  2. Severity of symptoms

    The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score

    Measured: Measured following 6 weeks of intervention (primary endpoint)

  3. Severity of symptoms

    The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score

    Measured: Measured 6 months after the primary endpoint (secondary endpoint)

Secondary outcomes (10)
  1. Health-Related Quality of life (HRQL)

    HRQL is assessed using the Danish version of the Short Form-36

    Measured: Measured at baseline

  2. Health-Related Quality of life (HRQL)

    HRQL is assessed using the Danish version of the Short Form-36

    Measured: Measured following 6 weeks of intervention (primary endpoint)

  3. Health-Related Quality of life (HRQL)

    HRQL is assessed using the Danish version of the Short Form-36

    Measured: Measured 6 months after the primary endpoint (secondary endpoint)

  4. Self-reported physical activity

    The International Physical Activity Questionnaire (IPAQ) short form

    Measured: Measured at baseline

  5. Self-reported physical activity

    The International Physical Activity Questionnaire (IPAQ) short form

    Measured: Measured following 6 weeks of intervention (primary endpoint)

  6. Self-reported physical activity

    The International Physical Activity Questionnaire (IPAQ) short form

    Measured: Measured 6 months after the primary endpoint (secondary endpoint)

  7. Range of motion

    Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer

    Measured: Measured at baseline

  8. Range of motion

    Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer

    Measured: Measured following 6 weeks of intervention (primary endpoint)

  9. Pain sensitivity

    Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer

    Measured: Measured at baseline

  10. Pain sensitivity

    Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer

    Measured: Measured following 6 weeks of intervention (primary endpoint)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2024
  2. Study start31 Oct 2024
  3. Primary completion30 Aug 2026 (estimated)
  4. Study completion30 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06487741
Sponsor's protocol ID
Fibromyalgia RCT
Status last verified
Nov 2024
First submitted
27 Jun 2024
Last updated
17 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study protocol will be published open access. Data is made available upon reasonable request.

Publications

  • Stove MP, Magnusson SP, Thomsen JL, Riis A. Efficacy of a home-based stretching programme on fibromyalgia symptoms: study protocol for a randomised controlled trial. Trials. 2025 Feb 27;26(1):74. doi: 10.1186/s13063-025-08776-z.

    PubMed 40016827

Questions about this trial

What is this clinical trial studying?

A study testing Home-based stretching exercises in people with Fibromyalgia and Stretch, run by University College of Northern Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Morten P Støve, PT. Msc. (72691004, mps@ucn.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Severity of symptoms (time frame: Measured at baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06487741, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in